Target intelligence / Profile preview

Pleckstrin homology domain-containing family F member 2 (PLEKHF2)

Target
PLEKHF2
Molecular classification
Other (phosphoinositide-binding protein, intracellular trafficking protein)
01

Overview

Pleckstrin homology domain-containing family F member 2 (PLEKHF2) is a cytosolic protein predicted to bind phosphatidylinositols via its pleckstrin homology (PH) and FYVE domains, directing it to specific membrane compartments such as endosomes. It is likely involved in early endosome fusion upstream of the small GTPase RAB5, thereby regulating receptor trafficking and fluid-phase transport. PLEKHF2 may also enhance cellular sensitivity to tumor necrosis factor (TNF)-induced apoptosis, suggesting a role in cell death processes. While structurally related to other PH/FYVE superfamily members, it has no current evidence of being a direct drug target or therapeutic receptor. The gene product is a phosphoinositide-binding protein involved in endosomal membrane trafficking and apoptosis. The protein is encoded by the PLEKHF2 gene (HGNC: 20757) and has no established clinical role as a biomarker or approved drug target. No known small molecule drugs or therapeutic antibodies interact with PLEKHF2 as of current sources, nor is it classified as a traditional receptor, enzyme, ion channel, or transporter. Its major function is predicted, not fully characterized experimentally, primarily inferred from bioinformatics and limited functional studies in cellular models.

Other names
ZFYVE18PHAFIN2Phafin2EAPFEndoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domainsPleckstrin homology and FYVE domain containing 2Pleckstrin homology domain-containing family F member 2PH and FYVE domain-containing protein 2Zinc finger FYVE domain-containing protein 18FLJ13187
02

Biological functions

Endosome organizationEndosome-to-lysosome transportPhosphatidylinositol binding activityApoptosis modulationRegulation of receptor trafficking
03

Disease associations

Other (no well-established disease role, but implicated in apoptosis and possibly cancer-related pathways)

Beyond the preview

Go deeper on Pleckstrin homology domain-containing family F member 2 (PLEKHF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pleckstrin homology domain-containing family F member 2 (PLEKHF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call